Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Prescription Gastrointestinal Drugs Market Growth 2022-2028

  • LP 4799002
  • 97 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prescription Gastrointestinal Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Prescription Gastrointestinal Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prescription Gastrointestinal Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Prescription Gastrointestinal Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prescription Gastrointestinal Drugs market, reaching US$ million by the year 2028. As for the Europe Prescription Gastrointestinal Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Prescription Gastrointestinal Drugs players cover AstraZeneca, Axcan Pharmaceuticals, Eisai, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Gastrointestinal Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral

Topical

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AstraZeneca

Axcan Pharmaceuticals

Eisai

GlaxoSmithKline

Merck

Salix Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prescription Gastrointestinal Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prescription Gastrointestinal Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prescription Gastrointestinal Drugs by Country/Region, 2017, 2022 & 2028

2.2 Prescription Gastrointestinal Drugs Segment by Type

2.2.1 Oral

2.2.2 Topical

2.3 Prescription Gastrointestinal Drugs Sales by Type

2.3.1 Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Prescription Gastrointestinal Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prescription Gastrointestinal Drugs Sale Price by Type (2017-2022)

2.4 Prescription Gastrointestinal Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Online Pharmacies

2.4.3 Retail Pharmacies

2.5 Prescription Gastrointestinal Drugs Sales by Application

2.5.1 Global Prescription Gastrointestinal Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Prescription Gastrointestinal Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prescription Gastrointestinal Drugs Sale Price by Application (2017-2022)

3 Global Prescription Gastrointestinal Drugs by Company

3.1 Global Prescription Gastrointestinal Drugs Breakdown Data by Company

3.1.1 Global Prescription Gastrointestinal Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Prescription Gastrointestinal Drugs Sales Market Share by Company (2020-2022)

3.2 Global Prescription Gastrointestinal Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Prescription Gastrointestinal Drugs Revenue by Company (2020-2022)

3.2.2 Global Prescription Gastrointestinal Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Prescription Gastrointestinal Drugs Sale Price by Company

3.4 Key Manufacturers Prescription Gastrointestinal Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prescription Gastrointestinal Drugs Product Location Distribution

3.4.2 Players Prescription Gastrointestinal Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prescription Gastrointestinal Drugs by Geographic Region

4.1 World Historic Prescription Gastrointestinal Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Prescription Gastrointestinal Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prescription Gastrointestinal Drugs Annual Revenue by Geographic Region

4.2 World Historic Prescription Gastrointestinal Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Prescription Gastrointestinal Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prescription Gastrointestinal Drugs Annual Revenue by Country/Region

4.3 Americas Prescription Gastrointestinal Drugs Sales Growth

4.4 APAC Prescription Gastrointestinal Drugs Sales Growth

4.5 Europe Prescription Gastrointestinal Drugs Sales Growth

4.6 Middle East & Africa Prescription Gastrointestinal Drugs Sales Growth

5 Americas

5.1 Americas Prescription Gastrointestinal Drugs Sales by Country

5.1.1 Americas Prescription Gastrointestinal Drugs Sales by Country (2017-2022)

5.1.2 Americas Prescription Gastrointestinal Drugs Revenue by Country (2017-2022)

5.2 Americas Prescription Gastrointestinal Drugs Sales by Type

5.3 Americas Prescription Gastrointestinal Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prescription Gastrointestinal Drugs Sales by Region

6.1.1 APAC Prescription Gastrointestinal Drugs Sales by Region (2017-2022)

6.1.2 APAC Prescription Gastrointestinal Drugs Revenue by Region (2017-2022)

6.2 APAC Prescription Gastrointestinal Drugs Sales by Type

6.3 APAC Prescription Gastrointestinal Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prescription Gastrointestinal Drugs by Country

7.1.1 Europe Prescription Gastrointestinal Drugs Sales by Country (2017-2022)

7.1.2 Europe Prescription Gastrointestinal Drugs Revenue by Country (2017-2022)

7.2 Europe Prescription Gastrointestinal Drugs Sales by Type

7.3 Europe Prescription Gastrointestinal Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prescription Gastrointestinal Drugs by Country

8.1.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Type

8.3 Middle East & Africa Prescription Gastrointestinal Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prescription Gastrointestinal Drugs

10.3 Manufacturing Process Analysis of Prescription Gastrointestinal Drugs

10.4 Industry Chain Structure of Prescription Gastrointestinal Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prescription Gastrointestinal Drugs Distributors

11.3 Prescription Gastrointestinal Drugs Customer

12 World Forecast Review for Prescription Gastrointestinal Drugs by Geographic Region

12.1 Global Prescription Gastrointestinal Drugs Market Size Forecast by Region

12.1.1 Global Prescription Gastrointestinal Drugs Forecast by Region (2023-2028)

12.1.2 Global Prescription Gastrointestinal Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prescription Gastrointestinal Drugs Forecast by Type

12.7 Global Prescription Gastrointestinal Drugs Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Prescription Gastrointestinal Drugs Product Offered

13.1.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Axcan Pharmaceuticals

13.2.1 Axcan Pharmaceuticals Company Information

13.2.2 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Offered

13.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Axcan Pharmaceuticals Main Business Overview

13.2.5 Axcan Pharmaceuticals Latest Developments

13.3 Eisai

13.3.1 Eisai Company Information

13.3.2 Eisai Prescription Gastrointestinal Drugs Product Offered

13.3.3 Eisai Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eisai Main Business Overview

13.3.5 Eisai Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Offered

13.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 Merck

13.5.1 Merck Company Information

13.5.2 Merck Prescription Gastrointestinal Drugs Product Offered

13.5.3 Merck Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck Main Business Overview

13.5.5 Merck Latest Developments

13.6 Salix Pharmaceuticals

13.6.1 Salix Pharmaceuticals Company Information

13.6.2 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Offered

13.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Salix Pharmaceuticals Main Business Overview

13.6.5 Salix Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Prescription Gastrointestinal Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prescription Gastrointestinal Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Topical

Table 5. Global Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Prescription Gastrointestinal Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Prescription Gastrointestinal Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Prescription Gastrointestinal Drugs Revenue by Application (2017-2022)

Table 13. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Prescription Gastrointestinal Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Prescription Gastrointestinal Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Prescription Gastrointestinal Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Prescription Gastrointestinal Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Prescription Gastrointestinal Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Prescription Gastrointestinal Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Prescription Gastrointestinal Drugs Producing Area Distribution and Sales Area

Table 21. Players Prescription Gastrointestinal Drugs Products Offered

Table 22. Prescription Gastrointestinal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Prescription Gastrointestinal Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Prescription Gastrointestinal Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Prescription Gastrointestinal Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Prescription Gastrointestinal Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Prescription Gastrointestinal Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Prescription Gastrointestinal Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Prescription Gastrointestinal Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Prescription Gastrointestinal Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Prescription Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Prescription Gastrointestinal Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Prescription Gastrointestinal Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Prescription Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Prescription Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Prescription Gastrointestinal Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Prescription Gastrointestinal Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Prescription Gastrointestinal Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Prescription Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Prescription Gastrointestinal Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Prescription Gastrointestinal Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Prescription Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Prescription Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Prescription Gastrointestinal Drugs

Table 66. Key Market Challenges & Risks of Prescription Gastrointestinal Drugs

Table 67. Key Industry Trends of Prescription Gastrointestinal Drugs

Table 68. Prescription Gastrointestinal Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Prescription Gastrointestinal Drugs Distributors List

Table 71. Prescription Gastrointestinal Drugs Customer List

Table 72. Global Prescription Gastrointestinal Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Prescription Gastrointestinal Drugs Sales Market Forecast by Region

Table 74. Global Prescription Gastrointestinal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Prescription Gastrointestinal Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Prescription Gastrointestinal Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Prescription Gastrointestinal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Prescription Gastrointestinal Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Prescription Gastrointestinal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Prescription Gastrointestinal Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Prescription Gastrointestinal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Prescription Gastrointestinal Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Prescription Gastrointestinal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Prescription Gastrointestinal Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Prescription Gastrointestinal Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Prescription Gastrointestinal Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Prescription Gastrointestinal Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Prescription Gastrointestinal Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Prescription Gastrointestinal Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Prescription Gastrointestinal Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Prescription Gastrointestinal Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. AstraZeneca Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. AstraZeneca Prescription Gastrointestinal Drugs Product Offered

Table 94. AstraZeneca Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. AstraZeneca Main Business

Table 96. AstraZeneca Latest Developments

Table 97. Axcan Pharmaceuticals Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Offered

Table 99. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Axcan Pharmaceuticals Main Business

Table 101. Axcan Pharmaceuticals Latest Developments

Table 102. Eisai Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Eisai Prescription Gastrointestinal Drugs Product Offered

Table 104. Eisai Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Eisai Main Business

Table 106. Eisai Latest Developments

Table 107. GlaxoSmithKline Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. GlaxoSmithKline Prescription Gastrointestinal Drugs Product Offered

Table 109. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. GlaxoSmithKline Main Business

Table 111. GlaxoSmithKline Latest Developments

Table 112. Merck Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Merck Prescription Gastrointestinal Drugs Product Offered

Table 114. Merck Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Merck Main Business

Table 116. Merck Latest Developments

Table 117. Salix Pharmaceuticals Basic Information, Prescription Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Offered

Table 119. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Salix Pharmaceuticals Main Business

Table 121. Salix Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Prescription Gastrointestinal Drugs

Figure 2. Prescription Gastrointestinal Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prescription Gastrointestinal Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prescription Gastrointestinal Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prescription Gastrointestinal Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Topical

Figure 11. Global Prescription Gastrointestinal Drugs Sales Market Share by Type in 2021

Figure 12. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Prescription Gastrointestinal Drugs Consumed in Hospital Pharmacies

Figure 14. Global Prescription Gastrointestinal Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 15. Prescription Gastrointestinal Drugs Consumed in Online Pharmacies

Figure 16. Global Prescription Gastrointestinal Drugs Market: Online Pharmacies (2017-2022) & (K Units)

Figure 17. Prescription Gastrointestinal Drugs Consumed in Retail Pharmacies

Figure 18. Global Prescription Gastrointestinal Drugs Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 19. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application in 2021

Figure 21. Prescription Gastrointestinal Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Prescription Gastrointestinal Drugs Revenue Market Share by Company in 2021

Figure 23. Global Prescription Gastrointestinal Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Prescription Gastrointestinal Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Prescription Gastrointestinal Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Prescription Gastrointestinal Drugs Sales 2017-2022 (K Units)

Figure 28. Americas Prescription Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Prescription Gastrointestinal Drugs Sales 2017-2022 (K Units)

Figure 30. APAC Prescription Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Prescription Gastrointestinal Drugs Sales 2017-2022 (K Units)

Figure 32. Europe Prescription Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Prescription Gastrointestinal Drugs Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Prescription Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Prescription Gastrointestinal Drugs Sales Market Share by Country in 2021

Figure 36. Americas Prescription Gastrointestinal Drugs Revenue Market Share by Country in 2021

Figure 37. United States Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Prescription Gastrointestinal Drugs Sales Market Share by Region in 2021

Figure 42. APAC Prescription Gastrointestinal Drugs Revenue Market Share by Regions in 2021

Figure 43. China Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Prescription Gastrointestinal Drugs Sales Market Share by Country in 2021

Figure 50. Europe Prescription Gastrointestinal Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Prescription Gastrointestinal Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Prescription Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Prescription Gastrointestinal Drugs in 2021

Figure 64. Manufacturing Process Analysis of Prescription Gastrointestinal Drugs

Figure 65. Industry Chain Structure of Prescription Gastrointestinal Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390